Upgrade to SI Premium - Free Trial

Allergan Generics (AGN), Teva Pharma (TEVA) Deal has $2.5B Termination Fee

July 28, 2015 9:14 AM
Allergan (NYSE: AGN) disclosed the following in an 8-K filed with the U.S. SEC on Tuesday morning:Allergan plc, a public ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Mergers and Acquisitions

Next Articles